MTOR and kidney disorder: Everolimus, an mTOR inhibitor that suppresses lymphocyte activation by blocking growth-dependent signal transduction in T and B cells (National Institute of Diabetes Digestive Kidney Diseases, 2012), showed substantial downregulation similarity with Lactobacillus crispatus and other Lactobacillus spp.